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Abstract: 
Advanced technology has made it possible to build machines and systems like robots, which are capable of making 
intelligent decisions. Robots capable of self-replication and perform human functions are also available. The current 
challenge is to design evolutionary systems with high complexity comparable to that of biological networks. This is 
proposed to be achieved by ALife (Artificial Life). Here, we describe the promises provided by ALife for life sciences.  
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Cellular automatons and biology: 
Jon Von Neumann, arguably, laid the foundations for the 
field of ALife. His UC (Universal Constructor) 
demonstrated evolutionary growth of complexity in a 
machine, akin to biological evolution. [1]  The UC, a 
machine, is isolated from its own definition, analogous to 
the genotype and phenotype of a biological organism. The 
UC is also capable of self-replication coupled with growth 
in complexity. Other such and more advanced systems have 
also been created, some based on the UC and some not. 
Examples of these are the Game of Life, Tierra etc., which 
provide a way of studying artificial self-replication and 
natural selection in their own environments. [1] 
Appropriate mathematical conditions are to be imposed in 
such computer systems to eliminate trivial self-
reproduction or “un-inheritable mutations”, to be useful 
from a practical biological viewpoint.  
 
Hence, ALife is a powerful tool for studying, simulating, 
and recreating biological systems and processes. The Von 
Neumann UC, a cellular automaton, has been a motivation 
for creating complex systems which are similar to 
biological systems. Its capability for universal computation 
also provides a basis for developing intelligent and 
complex systems which may find direct application in 
synthetic biology. The challenge, however, is in 
formalizing the notion of adaptive complexity in biology 
which is a grand challenge for evolutionary biology and 
ALife. [1]  
 
Scope of artificial life: 
ALife adopts a bottom-up methodology in designing 
systems or simulations that are life-like, with characteristics 
such as growth, death, evolution etc. That is, starting from 
the simplest elements and aggregating them to form 
complex systems. Artificial Intelligence, on the other hand 
looks to solve specific problems using human-like 
behavior, but not to build complex systems from scratch. 
Thus, these two 'artificial' fields are fundamentally 
different, each having its own professed goals. The goal of 
ALife is to study ‘intelligence’ or ‘logic’ underlying natural 
processes and using them in recreating alternative media 
like hardware or synthetic organs for humans. [2] With 
effective computation, one may be able to integrate the 
simulations of key components of biological networks to 
the level of macromolecular kinetics, which would provide 
further insight into biological systems. [3] 
 
ALife not only helps simulate and understand natural 
processes but ALife is also aimed at building systems in the 
real world based on these processes. [2] ALife is already 
finding application in building physical devices such as 
evolvable hardware and robots, and in network and cyber 
security. The motivation has been from biological systems 
like the immune systems in nature. [4] More such robust 
systems can be designed by studying the natural and highly 
adaptive processes. 
 
Artificial life and synthetic biology: 
Synthetic biology is similar to the science of genetically 
engineered microorganisms. [5] In this respect, ALife and 
synthetic biology are foundationally similar. ALife is aimed 
at abstracting away the process of life from the natural 
medium and provides a novel alternative in redesigning 
biological systems using bottom-up methodology. 
Comparisons can, thus, be made between observed and 
predicted behavior aiding in the study of biological 
systems. The self replication of cellular automatons, with 
their similarity to biological systems, may prove to be a 
handy tool in designing cells and systems. This process will 
typically involve integrating various modeled biological 
components and data to form biological systems. [6]  
 
Living systems are composed of macromolecules (DNA, 
RNA, proteins, carbohydrates, lipds, water and mineral 
salts). However, molecules performing similar functions 
can be designed. Synthetic biologists propose to design 
such molecules and systems for simulating natural Bioinformation by Biomedical Informatics Publishing Group    open access 
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processes in living cells. [5] Building such alternative life 
needs effective simulation and modeling tools for study and 
design. The greatest challenge is the creation of standards 
for such designed components to allow interchangeability. 
An example is the Registry of Standard Biological Parts, 
which has been set up by the MIT team. [7] An existing, 
yet an exemplary standard, is the PoPS (Polymerase per 
Second) which is the flow of RNA polymerase over DNA 
and is independent of the DNA sequence. The challenge 
thus, is to bring an engineering approach to ALife towards 
the designing of biological systems.  
 
Applied research on cost effective drug discovery systems 
through alternative molecules, energy generation from 
microorganisms and bioremediation uses fundamental 
evolutionary concepts in ALife. Nonetheless, a concerted 
effort in formalizing interdisciplinary ALife and Biology 
research to achieve the common goal of studying and 
recreating life-like and living systems is lacking. Designing 
living systems is non-trivial and future developments in 
ALife finds application in medicine and biotechnology.  
 
 
Conclusion: 
Artificial Life is an interdisciplinary science involving 
psychology, cognitive science, mathematics, biology and 
complex computations. Development of models in 
synthetic biology with appropriate validation finds 
enormous application in biomedicine. In its current status, 
standardization of synthesized biological components and 
formalization of methodologies remains as a challenge. 
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